Development of a Universal Nasal Spray Vaccine
A recent breakthrough by Stanford University researchers has led to the development of a universal nasal spray vaccine, a mucosal vaccine administered through the nose rather than injection. It targets multiple respiratory pathogens including SARS-CoV-2, Influenza A/B, and Streptococcus pneumoniae. The vaccine uses synthetic nanoparticles and immune-boosting adjuvants to activate IgA (Immunoglobulin A) antibodies at mucosal surfaces such as t
Sign up free to read the full article
Access all current affairs, state notes, subject notes and more — completely free.